5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
about
Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3)Monoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesSchizophrenia drug discovery and development in an evolving era: are new drug targets fulfilling expectations?We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.Potential serotonergic agents for the treatment of schizophrenia.Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model.Atypical antipsychotics and inverse agonism at 5-HT2 receptors.5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.Repeated administration of 5-hydroxytryptamine 2C agonist MK212 produces a sensitization effect of antipsychotic activity.
P2860
Q26783258-08D562DE-DE9B-474B-9B06-A41C4BF66760Q28066691-717352DD-7E50-429E-B411-23CB52A74034Q34458090-885D617D-5CDE-40AE-994D-F027A64A9129Q35823591-8993BF25-D796-4FD8-BD80-2A9B1DB864B8Q36805380-D075E4EC-D0AE-4897-B69E-73C3335F4149Q37707718-AC07676B-D15D-439D-A31C-00F551207AD0Q38635792-BC11F714-BAAF-4321-9F77-0A5352C3DE84Q39267434-F3B058E4-761E-4749-A927-052627433A15Q41250110-84ED655B-D76E-4787-9095-49281EE41282Q47357220-AABCB241-37C9-457D-8847-1B71E29C3241Q50038117-A63270FC-0162-4B6E-B126-D0BC77783100
P2860
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
@en
type
label
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
@en
prefLabel
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
@en
P2093
P1476
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia.
@en
P2093
John Dunlop
Jonathan Gross
Karen L Marquis
Sharon Rosenzweig-Lipson
Thomas A Comery
P304
P356
10.1007/978-3-642-25758-2_6
P577
2012-01-01T00:00:00Z